Specifically, TNFR2 promotes tumorigenesis and progression of pancreatic cancer via cancer immunosuppression with increased number of Tregs and decreased numbers of CD3+CD8+T cells. This evidence concerns the gene TNFRSF1B and pancreatic neoplasm.